Bank of the West’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.26M | Sell |
24,215
-536
| -2% | -$51.7K | 0.27% | 102 |
|
|
2022
Q3 | $2.36M | Sell |
24,751
-1,260
| -5% | -$125K | 0.31% | 92 |
|
|
2022
Q2 | $2.41M | Sell |
26,011
-4,016
| -13% | -$392K | 0.31% | 91 |
|
|
2022
Q1 | $3.04M | Sell |
30,027
-540
| -2% | -$56.7K | 0.31% | 86 |
|
|
2021
Q4 | $3.15M | Sell |
30,567
-39,241
| -56% | -$3.63M | 0.3% | 89 |
|
|
2021
Q3 | $5.92M | Buy |
69,808
+1,997
| +3% | +$167K | 0.62% | 47 |
|
|
2021
Q2 | $5.66M | Buy |
67,811
+680
| +1% | +$55.7K | 0.58% | 52 |
|
|
2021
Q1 | $5.05M | Sell |
67,131
-191
| -0.3% | -$13.9K | 0.57% | 52 |
|
|
2020
Q4 | $4.6M | Buy |
67,322
+2,115
| +3% | +$138K | 0.54% | 53 |
|
|
2020
Q3 | $3.81M | Sell |
65,207
-8,606
| -12% | -$535K | 0.51% | 55 |
|
|
2020
Q2 | $4.8M | Sell |
73,813
-3,960
| -5% | -$249K | 0.65% | 41 |
|
|
2020
Q1 | $4.62M | Sell |
77,773
-5,673
| -7% | -$379K | 0.72% | 39 |
|
|
2019
Q4 | $6.2M | Buy |
83,446
+1,201
| +1% | +$84.3K | 0.73% | 37 |
|
|
2019
Q3 | $5.19M | Buy |
82,245
+2,421
| +3% | +$143K | 0.63% | 42 |
|
|
2019
Q2 | $4.35M | Sell |
79,824
-3,941
| -5% | -$212K | 0.51% | 55 |
|
|
2019
Q1 | $4.52M | Buy |
83,765
+10,744
| +15% | +$663K | 0.53% | 53 |
|
|
2018
Q4 | $4.78M | Sell |
73,021
-21,584
| -23% | -$1.61M | 0.58% | 47 |
|
|
2018
Q3 | $7.45M | Buy |
94,605
+8,825
| +10% | +$631K | 0.87% | 29 |
|
|
2018
Q2 | $5.52M | Sell |
85,780
-879
| -1% | -$57.9K | 0.68% | 40 |
|
|
2018
Q1 | $5.39M | Buy |
86,659
+9,067
| +12% | +$651K | 0.68% | 43 |
|
|
2017
Q4 | $5.63M | Sell |
77,592
-11,139
| -13% | -$810K | 0.7% | 43 |
|
|
2017
Q3 | $7.22M | Buy |
88,731
+2,992
| +3% | +$237K | 0.91% | 28 |
|
|
2017
Q2 | $6.9M | Buy |
85,739
+2,732
| +3% | +$216K | 0.89% | 32 |
|
|
2017
Q1 | $6.52M | Buy |
83,007
+564
| +0.7% | +$45K | 0.82% | 34 |
|
|
2016
Q4 | $6.5M | Sell |
82,443
-1,989
| -2% | -$161K | 0.9% | 29 |
|
|
2016
Q3 | $7.51M | Buy |
84,432
+22,520
| +36% | +$2.13M | 1.04% | 23 |
|
|
2016
Q2 | $5.93M | Buy |
61,912
+9,338
| +18% | +$931K | 0.84% | 33 |
|
|
2016
Q1 | $5.45M | Sell |
52,574
-4,917
| -9% | -$478K | 0.75% | 36 |
|
|
2015
Q4 | $5.62M | Buy |
57,491
+455
| +0.8% | +$44.6K | 0.78% | 34 |
|
|
2015
Q3 | $5.5M | Sell |
57,036
-1,786
| -3% | -$188K | 0.88% | 30 |
|
|
2015
Q2 | $6.17M | Buy |
58,822
+2,104
| +4% | +$215K | 0.88% | 34 |
|
|
2015
Q1 | $5.85M | Buy |
56,718
+162
| +0.3% | +$16.4K | 0.82% | 34 |
|
|
2014
Q4 | $5.45M | Sell |
56,556
-806
| -1% | -$71K | 0.8% | 37 |
|
|
2014
Q3 | $4.57M | Buy |
57,362
+744
| +1% | +$58.7K | 0.78% | 40 |
|
|
2014
Q2 | $4.27M | Sell |
56,618
-10,845
| -16% | -$820K | 0.67% | 51 |
|
|
2014
Q1 | $5.05M | Sell |
67,463
-628
| -0.9% | -$44.4K | 0.83% | 36 |
|
|
2013
Q4 | $4.87M | Sell |
68,091
-1,879
| -3% | -$121K | 0.77% | 38 |
|
|
2013
Q3 | $3.97M | Sell |
69,970
-4,421
| -6% | -$263K | 0.72% | 46 |
|
|
2013
Q2 | $4.25M | Buy |
+74,391
| New | +$4.31M | 0.8% | 41 |
|
Other funds holding CVS
AWA
Bank of the West's CVS Position: Q4 2022 in Review
Bank of the West reduced its CVS Health (CVS) stake by 2.2% in Q4 2022, selling an estimated $51.7K and leaving 24,215 shares worth $2.26M. The position accounts for 0.27% of the portfolio, ranked #102.
Bank of the West first reported a position in CVS in Q2 2013 and has held it in 39 quarters since. The position peaked at $7.51M in Q3 2016. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.
- Bank of the West held 24,215 shares of CVS Health worth $2.26M as of Q4 2022.
- Bank of the West sold 536 CVS Health shares in Q4 2022, an estimated $51.7K.
- CVS Health made up 0.27% of Bank of the West's portfolio in Q4 2022, its #102 holding.
- Bank of the West first reported a position in CVS Health in Q2 2013 and has held it in 39 quarters since.
- Bank of the West's CVS Health position peaked at $7.51M in Q3 2016.
- 2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.
Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.